EA
TECX

Emerald Advisers’s Tectonic Therapeutic TECX Stock Holding History

Emerald Advisers’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,417
Closed -$6.13M – 290
2021
Q2 		$6.13M Sell
57,417
-19,018
-25% -$2.25M 0.22% 119
2021
Q1 		$11.6M Sell
76,435
-7,666
-9% -$1.25M 0.42% 95
2020
Q4 		$14.1M Buy
84,101
+16,891
+25% +$3M 0.47% 90
2020
Q3 		$10.5M Sell
67,210
-2,163
-3% -$436K 0.43% 79
2020
Q2 		$14.5M Buy
69,373
+3,156
+5% +$650K 0.63% 59
2020
Q1 		$12.4M Buy
66,217
+11,525
+21% +$2.71M 0.72% 52
2019
Q4 		$13.2M Sell
54,692
-146
-0.3% -$28.1K 0.56% 74
2019
Q3 		$9.29M Buy
54,838
+4,838
+10% +$1.1M 0.43% 91
2019
Q2 		$9.76M Sell
50,000
-1,201
-2% -$259K 0.39% 95
2019
Q1 		$13.5M Buy
51,201
+19,481
+61% +$3.56M 0.55% 72
2018
Q4 		$6.34M Buy
31,720
+189
+0.6% +$57.6K 0.31% 101
2018
Q3 		$19.6M Buy
31,531
+11,559
+58% +$5.12M 0.72% 61
2018
Q2 		$6.84M Buy
+19,972
New +$7.2M 0.26% 113

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Emerald Advisers's TECX Position: Q3 2021 in Review

Emerald Advisers sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 57,417 shares — an estimated $6.13M sold.

Emerald Advisers first reported a position in TECX in Q2 2018 and held it in 13 quarters. The position peaked at $19.6M in Q3 2018. 100 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Emerald Advisers reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Emerald Advisers sold 57,417 Tectonic Therapeutic shares in Q3 2021, an estimated $6.13M.
  • Emerald Advisers first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 13 quarters.
  • Emerald Advisers's Tectonic Therapeutic position peaked at $19.6M in Q3 2018.
  • 100 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.